查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423587

药物释放型球囊导管的全球市场预测（-2030）：按产品、药物、材料、最终用户和地区进行分析

Drug-eluting Balloon Catheters Market Forecasts to 2030 - Global Analysis By Product (Coronary Artery Balloon Catheters and Peripheral Vascular Balloon Catheters), Drug, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

2023年全球药物释放型球囊导管市场规模为6.51亿美元，预计预测期内复合年增长率为10.9%，到2030年达到13.432亿美元。称为药物药物释放型球囊导管 (DEB) 的医疗设备在介入性心臟病学中用于治疗周边动脉疾病(PAD) 和冠状动脉疾病 (CAD)。

这些导管的目的是将药物直接注射到受损的血管壁中，以阻止血管再阻塞，即血管成形术治疗后的血管收缩。由于药物涂层和导管技术的发展，以及专注于改善患者治疗效果和安全性的持续临床研究，药物释放型球囊导管市场正在不断变化。

根据美国心臟协会 2021 年的报告，周边动脉疾病(PAD) 影响全球 2 亿多人，并与高死亡率和发病率有关。此外，易患心血管疾病的老年人口的增加和医疗保健支出的增加预计将推动市场成长。

心血管疾病的盛行率

随着心血管疾病的发生率增加，需要介入治疗来控制动脉阻塞的患者数量也在增加。对于这些患者来说，药物释放型球囊导管是一种有效的治疗选择，可能会增加使用这些设备的治疗数量。此外，医疗保健费用也受到心血管疾病经济负担的影响，包括后续观察、住院和治疗。因此，如果药物释放型球囊导管被证明可以透过血管再阻塞和再手术来节省长期医疗成本，那么它们将成为创新和成功治疗方法的典范，从而推动市场成长，并有可能广泛应用。

根据病变类型，临床证据有限

支持使用药物释放型球囊导管的临床资料有限，可能会限制医疗保健负责人针对特定病变类型可用的有效治疗方法的数量。这种限制可能会阻止患有某些动脉病变的患者接受最佳治疗。这些导管被认为是潜在的良好替代品，特别是在缺乏可靠资料来支持其使用的情况下。虽然这些系统在某些情况下可能是有益的，但它们可能会导致选择更多基于证据的治疗方法，从而错失改善患者护理的机会，从而推动市场成长。

扩大临床证据

药物释放型球囊导管安全有效，具有良好的长期效果。此类资料支援其使用并鼓励医疗保健专业人员使用它。越来越多的临床资料证明药物释放型球囊导管的优越性可能会对医疗保健付款人的报销决策产生积极影响。事实证明，更好的患者治疗效果可能会带来更有利的报销规则，从而增加市场进入和设备利用率。

成本和报销挑战

患者使用药物释放型球囊导管可能会因支付问题而受到阻碍，特别是在保险范围和报销法律不利的地区和卫生系统中。这些限制可能会阻止患者平等地获得尖端治疗方法，并可能影响预后，这取决于保险状况和地理位置。保险报销困难或缺乏保险覆盖范围可能会阻碍药物释放型球囊导管市场的渗透和接受度。

COVID-19 的影响

在大流行最严重的时候，许多医院和医疗机构在获取资源时优先考虑 COVID-19 患者。因此，选择性手术，包括药物释放型球囊血管成形术等非紧急心臟介入措施，不得不延后或取消。因此，市场上使用这些设备进行的手术数量有所减少。随着疫苗接种率的提高和卫生系统适应这一流行病，选择性手术和非紧急干预措施已稳步恢復。一些医疗机构的重新开放导致对心血管治疗的需求增加，特别是那些需要球囊导管释放药物的治疗。

冠状动脉球囊导管领域预计将成为预测期内最大的市场

冠状动脉球囊导管可以疏通或拓宽冠状动脉，以补充心肌的血液供应，因此该领域有望迎来良好的成长。特别是，药物释放型球囊导管是一种将药物直接输送到动脉阻塞部位以避免血管再阻塞的导管。此外，对微创手术的需求、心血管疾病盛行率的上升以及药物释放型球囊比传统血管成形术更有效地降低血管再阻塞率这一事实正在推动市场成长。

紫杉醇细分市场预计在预测期内复合年增长率最高

由于担心其安全性，特别是其与周边动脉疾病(PAD) 患者的长期影响和死亡率增加的关係，紫杉醇在药物释放型球囊(DEB) 导管中的使用受到了广泛关注。研究正在进行中。此外，由于围绕这些设备的安全问题，药物释放型球囊导管和其他紫杉醇涂层产品的市场动态正在改变。因此，关于加强监测、改变临床程序、患者选择和长期安全性监测的讨论越来越多。

比最大的地区

由于多个领先製造商的存在、技术先进的新技术设备的引进、有利的报销政策等是北美市场占有率的主要因素，预计北美地区将在预测期内实现增长。争取最大的市场占有率。例如，美国心臟协会估计，美国每年进行超过 50 万例经皮经皮成形术，包括经皮腔内冠状动脉介入治疗。

复合年增长率最高的地区：

由于医疗保健成本上升和心血管疾病的流行，预计亚太地区在预测期内将呈现最高的复合年增长率。据Biomedcentral称，近五分之一的中国人患有心血管疾病。此外，由于可支配收入的增加和人口老化，预计中国和日本等国家的该行业需求将会增加。开发中国家健康旅游的成长也促进了该领域的产业进步。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球药物释放型球囊导管市场：副产品

  • 冠状动脉球囊导管
  • 末稍血管球囊导管

第六章全球药物释放型球囊导管市场：依药物分类

  • Sirolimus
  • 紫杉醇
  • 其他药品

第七章全球药物释放型球囊导管市场：依材料分类

  • 尼龙
  • 聚氨酯
  • 其他材料

第八章全球药物释放型球囊导管市场：依最终用户分类

  • 门诊手术中心
  • 导尿实验室
  • 医院和诊所
  • 其他最终用户

第九章全球药物释放型球囊导管市场：依地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 协议、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Aachen Resonance GmbH
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik AG
  • iVascular SLU
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • MedAlliance
  • Medtronic plc
  • Biosensors International
  • Eurocor GmbH
  • Zhejiang Barty Medical Technology Co.Ltd
  • Cook Group Incorporated
  • Terumo Corporation
  • SurModics Inc
  • Koninklijke Philips NV
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Cordis Corporation
  • Cardionovum GmbH
  • Abbott Laboratories
Product Code: SMRC24821

According to Stratistics MRC, the Global Drug-eluting Balloon Catheters Market is accounted for $651.0 million in 2023 and is expected to reach $1343.2 million by 2030 growing at a CAGR of 10.9% during the forecast period. Medical devices called drug-eluting balloon catheters (DEBs) are used in interventional cardiology to treat peripheral arterial disease (PAD) and coronary artery disease (CAD). The purpose of these catheters is to administer medication straight to the damaged blood vessel walls in order to stop restenosis, or the constriction of blood vessels after angioplasty treatments. With developments in drug coatings, catheter technology, and continuing clinical research focused on improving patient outcomes and safety, the market for drug-eluting balloon catheters is continually changing.

According to the American Heart Association 2021 report, peripheral artery disease (PAD) affects more than 200 million people worldwide and is associated with high mortality and morbidity. Moreover, the increasing geriatric population, which is prone to cardiovascular diseases and growing healthcare spending are projected to bolster market growth

Market Dynamics:

Driver:

Prevalence of cardiovascular diseases

The number of individuals in need of interventional therapies to control arterial blockages grows in tandem with the frequency of cardiovascular disorders. For these patients, drug-eluting balloon catheters provide an efficient therapeutic alternative that may result in an increase in the number of procedures using these devices. Additionally, healthcare cost is influenced by the financial burden of cardiovascular illnesses, which includes follow-up care, hospital stays, and therapies. Thus drug-eluting balloon catheters are one example of an innovative and successful treatment that may be more widely used if it can be demonstrated to save long-term healthcare expenditures by reducing restenosis and recurring procedures which encourage the growth of the market.

Restraint:

Limited clinical evidence in some lesion types

There may be fewer effective treatment choices available to healthcare practitioners for particular lesion types if there is limited clinical data supporting the use of drug-eluting balloon catheters. This restriction may result in patients with certain arterial lesions not receiving the best care possible, especially if these are thought to be a potentially good alternative but have no solid data to support their use. Even while these systems could be beneficial in some circumstances, they might choose more well-established therapies with more evidence, missing out on chances to improve patient care thereby propel the growth of the market.

Opportunity:

Expanding clinical evidence

Drug-eluting balloon catheters are safe, effective, and have good long-term results; this data supports their use and encourages healthcare practitioners to use them. Increased clinical data demonstrating the advantages of drug-eluting balloon catheters can have a favourable impact on healthcare payers' judgments about reimbursement. More proof of better patient outcomes might support reimbursement rules that are more favourable, increasing market access and device usage.

Threat:

Cost considerations and reimbursement challenges

Patients' access to drug-eluting balloon catheters may be hampered by payment issues, especially in areas or healthcare systems with unfavourable coverage or reimbursement laws. Due to this restriction, patients may not have equal access to cutting-edge therapies, which might have an effect on their prognosis depending on their insurance status or region. Difficulties with reimbursement or hold-ups in receiving positive coverage decisions might hinder drug-eluting balloon catheters market penetration and acceptance.

Covid-19 Impact

Many hospitals and healthcare facilities gave priority to COVID-19 patients when it came to resources during the pandemic's height. Elective operations, including non-urgent cardiac interventions like drug-eluting balloon angioplasty, had to be postponed or cancelled as a result. As a result, the number of procedures performed on the market for these devices decreased. Elective operations and non-urgent interventions showed a steady recovery as vaccination rates rose and healthcare systems adjusted to the epidemic. As a result of several healthcare institutions starting up again, there was an increase in demand for cardiovascular treatments, especially those requiring balloon catheters that release medication.

The coronary artery balloon catheters segment is expected to be the largest during the forecast period

The coronary artery balloon catheters segment is estimated to have a lucrative growth, as these gadgets are intended to unblock or widen coronary arteries in order to replenish blood supply to the heart muscle. In particular, drug-eluting balloon catheters are a kind of catheter that, in order to avoid restenosis, provide medication right to the location of an arterial blockage. Moreover these are becoming more and more popular; as these devices are driven by factors like the need for less invasive procedures, the prevalence of cardiovascular diseases rising, and the fact that drug-eluting balloons reduce restenosis rates more effectively than traditional angioplasty which drives the growth of the market.

The paclitaxel segment is expected to have the highest CAGR during the forecast period

The paclitaxel segment is anticipated to witness the highest CAGR growth during the forecast period, because its usage in drug-eluting balloon (DEB) catheters has drawn a lot of attention and investigation because of worries about its safety, especially in light of possible long-term consequences and a link to higher death rates in patients with peripheral artery disease (PAD). Furthermore, drug-eluting balloon catheters and other paclitaxel-coated goods have seen changes in their market dynamics due to safety concerns surrounding these devices. Thus increased scrutiny, modifications to clinical procedures and conversations about patient selection and long-term safety monitoring have resulted from it.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the availability of several large manufacturers, the introduction of new, technologically sophisticated equipment, and advantageous reimbursement policies are all key contributors to the market share that is seen in North America. For instance, according to estimates from the American Heart Association, more than 500,000 percutaneous coronary procedures including percutaneous transluminal coronary interventions are performed in the United States each year.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to both the rise in healthcare costs and the prevalence of cardiovascular diseases. According to Biomedcentral, almost one in five Chinese people suffer from cardiovascular disease. Furthermore, it is projected that growing disposable income and an older population in nations like China and Japan would fuel demand in the area. The growth of health tourism in developing nations is also contributing to the industry's progress in this sector.

Key players in the market

Some of the key players profiled in the Drug-eluting Balloon Catheters Market include Aachen Resonance GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik AG, iVascular S.L.U., Lepu Medical Technology (Beijing) Co. Ltd., MedAlliance, Medtronic plc, Biosensors International, Eurocor GmbH, Zhejiang Barty Medical Technology Co.Ltd, Cook Group Incorporated, Terumo Corporation, SurModics Inc, Koninklijke Philips NV, Jotech GmbH, MicroPort Scientific Corporation, Cordis Corporation, Cardionovum GmbH and Abbott Laboratories

Key Developments:

In November 2023, BD launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.

In October 2023, Philips OneBlade Partners with College Rivals for an Epic Gaming Journey Enabling Gen Z to 'Move Fearlessly' this is the third strategic partnership in a year that aims to strengthen the brand's commitment to reaching the GenZ audience.

In August 2023, Philips expands local manufacturing of Personal Health products in India to serve local demand, in addition to the beauty and grooming products already being made at the site.

Products Covered:

  • Coronary Artery Balloon Catheters
  • Peripheral Vascular Balloon Catheters

Drugs Covered:

  • Sirolimus
  • Paclitaxel
  • Other Drugs

Materials Covered:

  • Nylon
  • Polyurethane
  • Other Materials

End Users Covered:

  • Ambulatory Surgical Centers
  • Catheterization Laboratories
  • Hospitals & clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Drug-eluting Balloon Catheters Market, By Product

  • 5.1 Introduction
  • 5.2 Coronary Artery Balloon Catheters
  • 5.3 Peripheral Vascular Balloon Catheters

6 Global Drug-eluting Balloon Catheters Market, By Drug

  • 6.1 Introduction
  • 6.2 Sirolimus
  • 6.3 Paclitaxel
  • 6.4 Other Drugs

7 Global Drug-eluting Balloon Catheters Market, By Material

  • 7.1 Introduction
  • 7.2 Nylon
  • 7.3 Polyurethane
  • 7.4 Other Materials

8 Global Drug-eluting Balloon Catheters Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Catheterization Laboratories
  • 8.4 Hospitals & clinics
  • 8.5 Other End Users

9 Global Drug-eluting Balloon Catheters Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Aachen Resonance GmbH
  • 11.2 B. Braun Melsungen AG
  • 11.3 Becton, Dickinson and Company
  • 11.4 Biotronik AG
  • 11.5 iVascular S.L.U.
  • 11.6 Lepu Medical Technology(Beijing) Co. Ltd.
  • 11.7 MedAlliance
  • 11.8 Medtronic plc
  • 11.9 Biosensors International
  • 11.10 Eurocor GmbH
  • 11.11 Zhejiang Barty Medical Technology Co.Ltd
  • 11.12 Cook Group Incorporated
  • 11.13 Terumo Corporation
  • 11.14 SurModics Inc
  • 11.15 Koninklijke Philips NV
  • 11.16 Jotech GmbH
  • 11.17 MicroPort Scientific Corporation
  • 11.18 Cordis Corporation
  • 11.19 Cardionovum GmbH
  • 11.20 Abbott Laboratories

List of Tables

  • Table 1 Global Drug-eluting Balloon Catheters Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
  • Table 4 Global Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
  • Table 5 Global Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
  • Table 6 Global Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
  • Table 7 Global Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
  • Table 8 Global Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 9 Global Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
  • Table 10 Global Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 11 Global Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 12 Global Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 13 Global Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
  • Table 14 Global Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 15 Global Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
  • Table 16 Global Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
  • Table 17 Global Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
  • Table 20 North America Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
  • Table 21 North America Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
  • Table 22 North America Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
  • Table 23 North America Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
  • Table 24 North America Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
  • Table 25 North America Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 26 North America Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
  • Table 27 North America Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 28 North America Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 29 North America Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 30 North America Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 North America Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 32 North America Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
  • Table 33 North America Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
  • Table 34 North America Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
  • Table 37 Europe Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
  • Table 38 Europe Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
  • Table 39 Europe Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
  • Table 40 Europe Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
  • Table 41 Europe Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
  • Table 42 Europe Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 43 Europe Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
  • Table 44 Europe Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 45 Europe Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 46 Europe Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 47 Europe Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
  • Table 48 Europe Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 49 Europe Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
  • Table 50 Europe Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
  • Table 51 Europe Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
  • Table 54 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
  • Table 55 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
  • Table 56 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
  • Table 57 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
  • Table 58 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
  • Table 59 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 60 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
  • Table 61 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 62 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 63 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 64 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
  • Table 65 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 66 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
  • Table 67 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
  • Table 68 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
  • Table 71 South America Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
  • Table 72 South America Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
  • Table 73 South America Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
  • Table 74 South America Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
  • Table 75 South America Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
  • Table 76 South America Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 77 South America Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
  • Table 78 South America Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 79 South America Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 80 South America Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 81 South America Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
  • Table 82 South America Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 83 South America Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
  • Table 84 South America Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
  • Table 85 South America Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Product (2021-2030) ($MN)
  • Table 88 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2021-2030) ($MN)
  • Table 89 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2021-2030) ($MN)
  • Table 90 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Drug (2021-2030) ($MN)
  • Table 91 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2021-2030) ($MN)
  • Table 92 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2021-2030) ($MN)
  • Table 93 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 94 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Material (2021-2030) ($MN)
  • Table 95 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 96 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 97 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 98 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By End User (2021-2030) ($MN)
  • Table 99 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 100 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2021-2030) ($MN)
  • Table 101 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2021-2030) ($MN)
  • Table 102 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2021-2030) ($MN)